Table 5 Clinicopathological characteristics of RCC patients with and without CVs
Variables | CV (+) n = 56 | CV (−) n = 67 | P-value |
|---|---|---|---|
Sex (male); n (%) | 47 (83.9) | 53 (79.1) | 0.6432 |
Age (years); median (IQR) | 67 (59–72) | 59 (49–68) | *0.0012 |
BMI (kg/m2); median (IQR) | 23.5 (20.8–26.5) | 24.9 (21.3–27.2) | 0.1470 |
ECOG PS (≥1); n (%) | 7 (12.5) | 0 (0) | *0.0033 |
Charlson comorbidity index (≥1); n (%) | 22 (39.3) | 11 (16.4) | 0.3693 |
Tumor size (mm); median (IQR) | 30 (25–35) | 23 (17–30) | * < 0.0001 |
Tumor size > 2 cm | 51 (91.1) | 46 (68.7) | *0.0034 |
Tumor location; n (%) | |||
Right | 25 (44.6) | 29 (43.3) | 1.0000 |
Posterior | 23 (41.1) | 26 (38.8) | 0.8543 |
Lateral | 38 (67.9) | 38 (56.7) | 0.2639 |
Exophytic; n (%) | 55 (98.2) | 61 (91.0) | 0.1248 |
No round; n (%) | 43 (76.8) | 25 (37.3) | * < 0.0001 |
Heterogeneity; n (%) | 50 (89.3) | 47 (70.1) | *0.0058 |
CCC; n (%) | 52 (92.9) | 53 (79.1) | *0.0405 |
Papillary RCC; n (%) | 3 (5.3) | 5 (7.5) | 0.7266 |
Chromophobe RCC; n (%) | 1 (1.8) | 6 (9.0) | 0.1248 |
Other types of RCC; n (%) | 0 (0.0) | 3 (4.4) | 0.2499 |
pT3a; n (%) | 10 (17.8) | 4 (6.0) | *0.0482 |
Fuhrman grade 3, 4; n (%) | 14 (25.0) | 11 (16.4) | 0.2669 |
INFβ, γ; n (%) | 20 (35.7) | 13 (19.4) | 0.0650 |
Central necrosis (+); n (%) | 12 (21.4) | 14 (20.9) | 1.0000 |
MVI (+); n (%) | 31 (55.4) | 22 (32.8) | *0.0172 |